Please login to the form below

Not currently logged in
Email:
Password:

Indoco and Watson Pharma in deal

Indian company Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market

Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market.

Shares of the Mumbai-based Indoco surged 4.95 per cent on the Bombay Stock Exchange after the announcement.

Under this deal, Indoco will develop, manufacture and supply a number of products that currently have yearly sales of $679m.

Indoco's chairman and managing director Suresh G Kare has said it is a remarkable achievement to be out-licensing technology to a company of Watson's scale.

2nd February 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics